tiprankstipranks
Advertisement
Advertisement
IRLAB to Showcase Parkinson’s Pipeline at Gothenburg Life Science Day
PremiumCompany AnnouncementsIRLAB to Showcase Parkinson’s Pipeline at Gothenburg Life Science Day
2M ago
IRLAB Triggers USD 3 Million Milestone as First Patient Dosed in IRL757 Parkinson’s Apathy Trial
Premium
Company Announcements
IRLAB Triggers USD 3 Million Milestone as First Patient Dosed in IRL757 Parkinson’s Apathy Trial
2M ago
IRLAB Advances CNS Pipeline as 2025 Loss Widens and Cash Position Strengthens
Premium
Company Announcements
IRLAB Advances CNS Pipeline as 2025 Loss Widens and Cash Position Strengthens
2M ago
IRLAB Secures New Patent for Mesdopetam, Strengthening Market Position
PremiumCompany AnnouncementsIRLAB Secures New Patent for Mesdopetam, Strengthening Market Position
5M ago
IRLAB to Present at Redeye Technology & Life Science Day 2025
Premium
Company Announcements
IRLAB to Present at Redeye Technology & Life Science Day 2025
5M ago
IRLAB Therapeutics Appoints Nomination Committee for 2026 AGM
Premium
Company Announcements
IRLAB Therapeutics Appoints Nomination Committee for 2026 AGM
5M ago
IRLAB to Present at Redeye Neurology Event, Expanding Investor Engagement
PremiumCompany AnnouncementsIRLAB to Present at Redeye Neurology Event, Expanding Investor Engagement
7M ago
IRLAB Advances IRL757 for Apathy in Parkinson’s Disease with MSRD Partnership
Premium
Company Announcements
IRLAB Advances IRL757 for Apathy in Parkinson’s Disease with MSRD Partnership
7M ago
IRLAB Secures Extended Patent Protection for Mesdopetam in China
Premium
Company Announcements
IRLAB Secures Extended Patent Protection for Mesdopetam in China
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100